{Reference Type}: Journal Article
{Title}: Specifications of the ACMG/AMP guidelines for ACADVL variant interpretation.
{Author}: Flowers M;Dickson A;Miller MJ;Spector E;Enns GM;Baudet H;Pasquali M;Racacho L;Sadre-Bazzaz K;Wen T;Fogarty M;Fernandez R;Weaver MA;Feigenbaum A;Graham BH;Mao R;
{Journal}: Mol Genet Metab
{Volume}: 140
{Issue}: 3
{Year}: 2023 11 26
{Factor}: 4.204
{DOI}: 10.1016/j.ymgme.2023.107668
{Abstract}: Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency (VLCADD) is a relatively common inborn error of metabolism, but due to difficulty in accurately predicting affected status through newborn screening, molecular confirmation of the causative variants by sequencing of the ACADVL gene is necessary. Although the ACMG/AMP guidelines have helped standardize variant classification, ACADVL variant classification remains disparate due to a phenotype that can be nonspecific, the possibility of variants that produce late-onset disease, and relatively high carrier frequency, amongst other challenges. Therefore, an ACADVL-specific variant curation expert panel (VCEP) was created to facilitate the specification of the ACMG/AMP guidelines for VLCADD. We expect these guidelines to help streamline, increase concordance, and expedite the classification of ACADVL variants.